SMAD3 and lung carcinoma: Notably, a parallel mechanism was reported in lung cancer, where PSMD14 promotes metastasis by deubiquitinating Smad3 to augment TGF-β1/Smad3 signaling and is associated with poor patient prognosis (21, 38).